Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: AJNR Am J Neuroradiol. 2019 Jun 27;40(7):1132–1139. doi: 10.3174/ajnr.A6110

Table 1.

Overall survival stratified by progression status at week 8.

Sequence Progression by week 8? Progression by week 8? (R vs NR-NP)
No Yes R NR-NP P
N (%) Median OS (days) (95% CI) N (%) Median OS (days) (95% CI) N (%) Median OS (days) (95% CI) N (%) Median OS (days) (95% CI) N (%) Median OS (days) (95% CI)
2D 67 (91%)
303 (232,
400)		 7 (9%)
110 (74, 192)		 18 (24%)
364 (280,
510)		 49 (66%)
268 (217,
378)		 7 (9%)
110 (74, 192)
P<0.0001 (N=74) P=035: R vs NR-NP
dT1 67 (91%)
303 (232, 400)		 7 (9%)
110 (74, 192)		 28 (38%)
425.5 (311, 660)		 39 (53%)
223 (180, 276)		 7 (9%)
110 (74, 192)
P<0.0001 (N=74) P=0.01: R vs NR-NP